Ant Group Rolls Out Major Upgrade to Its Popular AI Health App

TLDRs;

• Ant Group’s AI health app AQ rebrands as Ant A-Fu, introducing major upgrades.
• App’s AI Q&A now analyzes images and explains medical test results accurately.
• Ant A-Fu connects users to 300,000 doctors, supporting appointments and insurance payments.
• Device makers and health platforms can access 15 million monthly users via app integration.

Ant Group has unveiled a significant update to its widely used AI health application, AQ, which now carries a new Chinese name, Ant A-Fu. Launched initially in June 2025, the app has quickly gained traction, reaching 15 million monthly active users.

The latest enhancements are designed to expand its capabilities in health guidance, AI-assisted consultations, and integrated medical services.

Advanced AI Q&A Enhances User Experience

The upgraded AI Q&A feature of Ant A-Fu is capable of analyzing medical images, simulating clinical consultations, and explaining test results in clear, accessible language. While the app offers comprehensive health insights, it explicitly does not provide official medical diagnoses or replace professional care.

This approach allows Ant A-Fu to position itself as a wellness companion, avoiding the regulatory oversight of China’s National Medical Products Administration (NMPA), which classifies devices with diagnostic functions as Class II medical devices requiring pre-market approval.

Seamless Connection to Professional Care

Ant A-Fu integrates with a network of 300,000 licensed doctors, allowing users to book consultations, purchase prescribed medications, and make payments using insurance certificates.

With partnerships including over 500 leading physicians, the app’s AI Doctor Agents have successfully addressed 27 million inquiries, demonstrating both the robustness of its AI capabilities and the growing adoption of digital health tools.

By combining AI guidance with real-world medical support, Ant A-Fu functions as a hybrid platform, offering triage and educational services rather than direct diagnosis.

Integration with Smart Devices and Health Platforms

A key feature of Ant A-Fu is its ability to sync health data from major smart devices, create family health profiles, and track personal wellness goals. This opens opportunities for wearable manufacturers and chronic disease device brands to reach engaged users directly.

Additionally, third-party health apps or medical device SaaS providers can integrate Ant A-Fu’s AI consultation layer into their own platforms, boosting retention and engagement while leveraging behavioral data for remote monitoring features.

Implications for Digital Health and AI Adoption

Ant Group’s expansion of AQ into Ant A-Fu reflects a broader trend of AI-driven health platforms bridging technology and care without overstepping regulatory boundaries. By emphasizing wellness guidance over direct diagnosis, the app manages to navigate China’s strict medical device regulations while offering a scalable platform for health services.

Its growing user base, sophisticated AI interactions, and robust integration capabilities suggest that Ant A-Fu could become a central hub for digital health management and AI-assisted medical guidance.

With over 1 billion users across multiple sectors through Ant Group’s ecosystem, including Alipay, Ant A-Fu is well-positioned to shape the future of AI health services in China. The platform demonstrates how digital technology, when combined with strategic partnerships and regulatory compliance, can enhance patient engagement, support healthcare providers, and drive adoption of AI-powered health solutions.

The post Ant Group Rolls Out Major Upgrade to Its Popular AI Health App appeared first on CoinCentral.